Drug Pipeline News

>

Latest News

FDA news in pediatrics: July 2025 | Image Credit: © Contemporary Pediatrics.
FDA news in pediatrics: July 2025

August 1st 2025

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from July 2025.

FDA approves concizumab-mtci for hemophilia A/B without inhibitors in patients 12 years and older | Image credit: Contemporary Pediatrics.
FDA approves concizumab-mtci for hemophilia A/B without inhibitors in patients 12 years and older

July 31st 2025

FDA grants fast track to rezpegaldesleukin for severe alopecia areata in ages 12 and up | Image credit: Contemporary Pediatrics
FDA grants fast track designation to rezpegaldesleukin for severe alopecia areata in patients 12 years and older

July 29th 2025

FDA approves pegcetacoplan as first treatment for C3 glomerulopathy or IC-MPGN | Image credit: Contemporary Pediatrics
FDA approves pegcetacoplan as first treatment for C3 glomerulopathy or IC-MPGN

July 29th 2025

WATCH: Experts react to the FDA approval of sepiapterin to treat PKU
WATCH: Experts react to the FDA approval of sepiapterin to treat PKU

July 29th 2025

Video Interviews
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.